| CORMEDIX INC. DL-,001 |
| USA |
| Gesundheit |
| US21900C3088 / A2PF3G |
| 19KA (Frankfurt) |
| FRA:19KA, ETR:19KA, 19KA:GR |
| - |
| http://www.cormedix.com/ |
|
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening conditions, particularly in anti-infective therapies and hospital-based treatments in the United States. Its lead product..
>Volltext.. |
| 479.29 Mio. EUR |
| 479.06 Mio. EUR |
| 266.94 Mio. EUR |
| 141.19 Mio. EUR |
| 139.64 Mio. EUR |
| 1.9 EUR |
| 127.53 Mio. EUR |
| 124.6 Mio. EUR |
| 149.91 Mio. EUR |
| 0.86 |
| 531.99% |
| - |
| - |
| - |
| - |
| - |
| CORMEDIX |
| 08.04.26 |
|